Streetbeat News

Price Targets

BWXT

Truist Securities analyst Michael Ciarmoli has maintained a Buy rating on BWX Technologies (NYSE:BWXT) and increased the price target from $90 to $105.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 3:00 pm

BEAM

RBC Capital analyst Luca Issi has maintained a 'Sector Perform' rating on Beam Therapeutics (NASDAQ:BEAM) and increased the price target from $27 to $35.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:58 pm

URBN

JP Morgan analyst Matthew Boss maintains a Neutral rating on Urban Outfitters (NASDAQ:URBN) and lowers the price target from $46 to $44.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:58 pm

PRGO

JP Morgan analyst Chris Schott maintains an Overweight rating on Perrigo (NYSE:PRGO) but lowers the price target from $48 to $41.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:57 pm

FSK

JP Morgan analyst Richard Shane has maintained a Neutral rating on FS KKR Capital (NYSE:FSK) and lowered the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:56 pm

BMBL

JP Morgan analyst Cory Carpenter maintains an Overweight rating on Bumble (NASDAQ:BMBL) but lowers the price target from $20 to $17.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:55 pm

ARRY

JP Morgan analyst Mark Strouse maintains an Overweight rating on Array Technologies (NASDAQ:ARRY) but lowers the price target from $35 to $29.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:53 pm

AMT

JP Morgan analyst Philip Cusick has maintained an Overweight rating on American Tower (NYSE:AMT) but has lowered the price target from $236 to $230.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:52 pm

AROC

RBC Capital analyst Elvira Scotto maintains an Outperform rating on Archrock (NYSE:AROC) and raises the price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:51 pm

ADNT

JP Morgan analyst Ryan Brinkman maintains a Neutral rating on Adient (NYSE:ADNT) and lowers the price target from $41 to $40.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 2:51 pm